Bayer Kogenate FS

Attention: Your browser does not support Javascript, or Javascript support has been disabled. This web site utilizes the latest Internet technology, and in order to experience the full functionality of this web site you will need to ensure that Javascript is enabled.















































	General Conditions of Use Privacy Statement Imprint

	This website is intended for U.S. Audiences Only.

	© 2008 Bayer HealthCare LLC BAYER, the Bayer Cross, and Kogenate are registered trademarks of Bayer BIO-SET is a trademark of Biodome SAS

Bayer Resources

Blood Coagulation Manual

At its most basic, hemophilia is a disorder of the coagulation system. The Bayer publication "Blood and Coagulation" provides an extensive discussion of blood, haemostasis and coagulation, and hemophilia.

Coming Soon! A downloadable version of the Blood and Coagulation Manual. Join Kogenate's mailing list to be notified when the manual is available.

Remember, your doctor or healthcare provider is the single best source of information regarding you and your health. Please consult your doctor if you have any questions about your health, your symptoms, or your therapy.

Hemophilia Basics

Publications

PEP

EZ-Log

Kogenate® FS, Antihemophilic Factor (Recombinant), is a recombinant factor VIII treatment indicated for the treatment of hemophilia A. The most frequently reported adverse events were local injection site reactions, dizziness, and rash. Known intolerance or allergic reactions to constituents of the preparation is a contraindication to the use of Kogenate® FS. Known hypersensitivity to mouse or hamster protein may be a contraindication to the use of Kogenate® FS. For important safety and use information, please see the full prescribing information.

Please consult your health care provider prior to making any lifestyle changes. The images used on this site do not necessarily represent actual Hemophilia patients.